145 related articles for article (PubMed ID: 22687440)
1. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.
Varshosaz J; Hassanzadeh F; Sadeghi H; Andalib S
Eur J Med Chem; 2012 Aug; 54():429-38. PubMed ID: 22687440
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
5. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
[TBL] [Abstract][Full Text] [Related]
6. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
Khajavinia A; Varshosaz J; Dehkordi AJ
Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592
[TBL] [Abstract][Full Text] [Related]
7. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
[TBL] [Abstract][Full Text] [Related]
10. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
11. Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design.
Andalib S; Varshosaz J; Hassanzadeh F; Sadeghi H
Adv Biomed Res; 2012; 1():45. PubMed ID: 23326776
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration.
Zhao C; Liu Y; Fan T; Zhou D; Yang Y; Jin Y; Zhang Z; Huang Y
Pharm Dev Technol; 2012; 17(4):443-56. PubMed ID: 21222507
[TBL] [Abstract][Full Text] [Related]
13. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
[TBL] [Abstract][Full Text] [Related]
14. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
Kasongo KW; Jansch M; Müller RH; Walker RB
J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells.
Varshosaz J; Jandaghian S; Mirian M; Sajjadi SE
J Liposome Res; 2021 Mar; 31(1):64-78. PubMed ID: 32138557
[TBL] [Abstract][Full Text] [Related]
17. Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.
Zhao C; Fan T; Yang Y; Wu M; Li L; Zhou Z; Jian Y; Zhang Q; Huang Y
Int J Pharm; 2013 Jun; 450(1-2):11-20. PubMed ID: 23612355
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
Fang CL; Al-Suwayeh SA; Fang JY
Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
[TBL] [Abstract][Full Text] [Related]
20. Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity.
Renck D; Machado P; Souto AA; Rosado LA; Erig T; Campos MM; Farias CB; Roesler R; Timmers LF; de Souza ON; Santos DS; Basso LA
J Med Chem; 2013 Nov; 56(21):8892-902. PubMed ID: 24131420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
